Angela Bazzi
Profiles

Angela R Bazzi, PhD

Adjunct Associate Professor, Community Health Sciences - Boston University School of Public Health

abazzi@bu.edu
View Full Profile at BUMC

Biography

Education

  • University of California, San Diego, PhD Field of Study: Public Health
  • Johns Hopkins University, MPH Field of Study: Public Health
  • University of Southern California, BA Field of Study: International Relations

Websites

Publications

  • Published on 9/11/2025

    Roth AM, Forman E, Akiba CF, Eger WH, Laurano R, Huffaker SL, Patel SV, Smith J, Lambdin BH, Bazzi AR. HIV Services Implementation Within US Syringe Services Programs: A Qualitative Exploration. AIDS Patient Care STDS. 2025 Sep 11. PMID: 40932685.

     Read At: PubMed
  • Published on 9/4/2025

    Weinstein ZM, Magane KM, Lodi S, Doeleman D, Ventura AS, Bazzi AR, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. Associations between COVID impact domains and time to buprenorphine treatment disengagement. Am J Drug Alcohol Abuse. 2025 Sep 04; 1-10. PMID: 40906491.

     Read At: PubMed
  • Published on 8/28/2025

    Theisen J, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Cheng A, Blakemore S, Blodgett J, Fielman S, Saitz R, Bazzi AR. Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment. Subst Use Addctn J. 2025 Aug 28; 29767342251360850. PMID: 40876939.

     Read At: PubMed
  • Published on 8/9/2025

    Paradise RK, Kimmel SD, Nurani A, Desmarais J, O'Malley S, Walley AY, Hoyos-Cespedes A, Clarke J, Taylor S, Dooley D, Bazzi AR. Building connection: overdose survivors' and professional service providers' perspectives on immediate post-overdose care. Int J Drug Policy. 2025 Aug 09; 145:104948. PMID: 40784254.

     Read At: PubMed
  • Published on 7/4/2025

    Plesons M, Eger WH, Crable EL, Hauschild MH, McElrath CC, Owens C, Forrest DW, Bazzi AR, De Los Santos N, Tookes HE, Bartholomew TS. Psychosocial consequences of xylazine and implications for harm reduction services. Drug Alcohol Depend Rep. 2025 Sep; 16:100357. PMID: 40687389.

     Read At: PubMed
  • Published on 5/27/2025

    Agénor M, Tipnis A, Byers M, Davis T, Noh M, Dunham R, Reyna K, Adesuyi Q, Bazzi AR, Biello KB. Structural barriers to sexual and reproductive health care among Black and Latina cisgender and transgender U.S. women who use drugs: a qualitative study. BMC Health Serv Res. 2025 May 27; 25(1):754. PMID: 40426121.

     Read At: PubMed
  • Published on 3/25/2025

    Eger WH, Gomez AK, Kielhold K, Bartholomew TS, Bazzi AR. Implementation determinants of safer smoking supplies in U.S. syringe services programs. Implement Sci Commun. 2025 Mar 25; 6(1):27. PMID: 40134039.

     Read At: PubMed
  • Published on 3/4/2025

    Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21. PMID: 40033433.

     Read At: PubMed
  • Published on 3/1/2025

    Eger WH, Shaw LC, Biello KB, Lopez C, Brody JK, Bazzi AR. HIV Pre-exposure Prophylaxis Prescription Initiation and Maintenance Among Homeless-Experienced People Who Use Drugs. J Acquir Immune Defic Syndr. 2025 Mar 01; 98(3):234-241. PMID: 39813325.

     Read At: PubMed
  • Published on 2/25/2025

    Bazzi AR, Roth AM, Akiba CF, Huffaker SL, Patel SV, Smith J, Laurano R, Orme S, Zarkin GA, Morgan-Lopez A, Lambdin BH. A systems analysis and improvement approach to optimizing syringe services programs' delivery of HIV testing and referrals: Study protocol for a parallel-group randomized controlled trial (SAIA-SSP-HIV). PLoS One. 2025; 20(2):e0319340. PMID: 39999129.

     Read At: PubMed

View 143 more publications:View Full Profile at BUMC

News & In the Media

View all profiles